- Home
- KNSA vs PGNY Comparison
KNSA vs PGNY Comparison
Compare KNSA & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- PGNY
- Stock Information
- Founded
- KNSA 2015
- PGNY 2008
- Country
- KNSA United Kingdom
- PGNY United States
- Employees
- KNSA N/A
- PGNY N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- PGNY Misc Health and Biotechnology Services
- Sector
- KNSA Health Care
- PGNY Health Care
- Exchange
- KNSA Nasdaq
- PGNY Nasdaq
- Market Cap
- KNSA 1.9B
- PGNY 1.8B
- IPO Year
- KNSA 2018
- PGNY 2019
- Fundamental
- Price
- KNSA $29.11
- PGNY $21.98
- Analyst Decision
- KNSA Strong Buy
- PGNY Buy
- Analyst Count
- KNSA 5
- PGNY 8
- Target Price
- KNSA $38.80
- PGNY $22.43
- AVG Volume (30 Days)
- KNSA 452.6K
- PGNY 1.2M
- Earning Date
- KNSA 07-22-2025
- PGNY 05-08-2025
- Dividend Yield
- KNSA N/A
- PGNY N/A
- EPS Growth
- KNSA N/A
- PGNY N/A
- EPS
- KNSA N/A
- PGNY 0.57
- Revenue
- KNSA $481,166,000.00
- PGNY $1,213,181,000.00
- Revenue This Year
- KNSA $37.21
- PGNY $6.75
- Revenue Next Year
- KNSA $5.32
- PGNY $11.16
- P/E Ratio
- KNSA N/A
- PGNY $38.92
- Revenue Growth
- KNSA 59.45
- PGNY 9.46
- 52 Week Low
- KNSA $17.38
- PGNY $13.39
- 52 Week High
- KNSA $29.67
- PGNY $30.42
- Technical
- Relative Strength Index (RSI)
- KNSA 70.29
- PGNY 52.26
- Support Level
- KNSA $26.58
- PGNY $20.95
- Resistance Level
- KNSA $27.90
- PGNY $22.03
- Average True Range (ATR)
- KNSA 1.01
- PGNY 0.68
- MACD
- KNSA 0.06
- PGNY 0.04
- Stochastic Oscillator
- KNSA 90.25
- PGNY 70.76
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.